
Attovia Therapeutics is developing biotherapeutics for immune-mediated diseases using ATTOBODY™, a proprietary biologics platform. ATTOBODIES achieve ultra-high affinity through biparatopic target engagement, enabling multi-specific biologics with tunable half-lives and quarterly dosing potential. The high-throughput discovery platform accelerates therapeutics development, positioning ATTOBODIES as the next-generation modality in the industry.
Attovia is seeking a Senior Director of In Vivo Pharmacology to lead the design, implementation, and oversight of in vivo studies. The role involves leading a small in vivo team, collaborating with cross-functional partners, managing resources, and supporting IND applications. The position requires a strong scientific background in immunology and inflammation.
Attovia Therapeutics is developing biotherapeutics for immune-mediated diseases using ATTOBODY™, a proprietary biologics platform. ATTOBODIES achieve ultra-high affinity through biparatopic target engagement, enabling multi-specific biologics with tunable half-lives and quarterly dosing potential. The high-throughput discovery platform accelerates therapeutics development, positioning ATTOBODIES as the next-generation modality in the industry.